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Abstract L-Carotene is discussed as an anti-oxidant micronu-
trient and singlet oxygen quencher in human skin, protecting
against UV light-induced damage. However, we recently
demonstrated that L-carotene has a pro-oxidant potential in
cultured human skin fibroblasts because it enhances the UVA
induction of heme oxygenase-1 (HO-1). Herein, we further show
that L-carotene also strongly promotes the UVA induction of
pro-inflammatory interleukin-6 (IL-6) in skin fibroblasts in vitro.
Singlet oxygen quencher sodium azide abrogated up-regulation
of IL-6, and likewise also of HO-1. In UVB-irradiated cells,
L-carotene did not modulate levels of IL-6 and HO-1. The
observed effects might be relevant for UV-induced inflammatory
processes. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Ultraviolet radiation, and mainly long-wavelength UVA
light (320^400 nm), is a strong oxidant, and overexposure to
sunlight provokes an in£ammatory stress response in skin
which acutely manifests as erythema (‘sunburn’) [1^3]. Anti-
oxidant micronutrients such as L-carotene (BC) have been
intensively studied for their potential in preventing skin pho-
todamage [4^6]. BC was found to protect from erythema for-
mation in humans [7^9], however, the mechanism how BC
modulates molecular events in UV-induced in£ammatory pro-
cesses in skin is unclear.
In UV-irradiated skin, photochemical reactions lead to the
formation of reactive oxygen species, and singlet molecular
oxygen (1O2) is considered the biologically most relevant
one [1]. BC is a scavenger of free radicals such as peroxyl
radicals, superoxide anions and hydroxyl radicals and, in par-
ticular, it is well-known as a potent quencher of 1O2 [10^12].
1O2 is a highly reactive non-radical form of molecular oxygen
generated in type II photodynamic reactions with photosensi-
tizers (e.g. porphyrins, £avins, quinones) [13], and it oxidizes a
large number of biological molecules, causing damage to lip-
ids, proteins, and DNA [14,15]. Besides, 1O2 mediates the
UVA-activation of a variety of genes which are involved in
cellular stress response and signal transduction pathways, and
it has been shown that 1O2 promotes UVA-induced apoptosis,
in£ammatory processes as well as early events in photoaging
[15,16].
Among the genes which are activated in dermal ¢broblasts
by UVA radiation, heme oxygenase-1 (HO-1; EC 1.14.99.3) is
the most strongly induced one that has been observed [17].
HO-1 is the inducible form of three isozymes of heme oxy-
genase, a microsomal enzyme which catalyzes the rate-limiting
step in heme catabolism [18]. Moreover, HO-1 is a sensitive
marker for oxidative stress induced by the substrate heme
itself, as well as a wide variety of cellular stressors including
reactive oxygen species such as hydrogen peroxide, hydroxyl
radical, nitric oxide, and 1O2 [17,19]. In dermal ¢broblasts,
photochemically generated 1O2 seems to be the main e¡ector
species for UVA-mediated HO-1 up-regulation [20].
Previously, we observed that BC strongly enhances the
stress response in UVA-irradiated skin ¢broblasts as deter-
mined by induction of HO-1 [21]. Consequently, we hypothe-
sized that BC does not signi¢cantly act as a 1O2 quencher in
UVA-irradiated skin ¢broblasts and that the observed pro-
oxidant potential of BC might also enhance in£ammatory
responses to UVA-induced oxidative stress such as production
of pro-in£ammatory cytokines. Dermal ¢broblasts are a ma-
jor target of UVA radiation in skin [22] and, in response to
UV exposure, they release a network of cytokines participat-
ing in the onset of cutaneous in£ammation, among them in-
terleukin-6 (IL-6) [23^25]. It has been shown that, via inter-
related autocrine loops, photochemically generated 1O2
induces in cultured skin ¢broblasts production and release
of IL-1 and IL-6, which results in an activation of matrix-
metalloproteinases and thus tissue degradation [26]. Besides,
IL-6 is a pleiotropic cytokine with numerous biological activ-
ities in skin and an important mediator of in£ammatory and
immunologic reactions [27]. The physiological role of IL-6 in
skin and in particular in skin ¢broblasts is only partly under-
stood. However, production and release of IL-6 seems to play
a crucial role in the pathogenesis of local and systemic sun-
burn reactions as well as photoaging of skin, tumor develop-
ment and autoimmune diseases such as lupus erythematosus
[27^29].
In this study we investigated the e¡ect of BC on the expres-
sion of IL-6 in human skin ¢broblasts following irradiation
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with suberythemal doses of UVA light in vitro. Furthermore,
we studied the role of BC as a 1O2 quencher in UVA-irradi-
ated cells modulating IL-6 and HO-1 inductions with sodium
azide (NaN3), and we determined whether the observed e¡ects
of BC occurred only following irradiation with UVA or also
UVB light. BC was used at physiologically relevant doses of
0.5 WM or 5 WM corresponding to human plasma levels with-
out or with moderate oral BC supplementation, respectively
[30].
2. Materials and methods
2.1. Chemicals
All chemicals were purchased from Sigma (Deisenhofen, Germany)
unless otherwise indicated. Tissue culture media, serum and supple-
ments were obtained either from Biochrom (Berlin, Germany) or from
Life Technologies (Paisley, UK). Commercial kits were used accord-
ing to the manufacturers’ protocols.
2.2. Cell culture
Normal human skin ¢broblasts (HFP-1), which had been derived
from biopsy material of the lower abdomen of a 3.5-year-old male
donor, were cultivated in Dulbecco’s modi¢ed Eagle’s medium sup-
plemented with 10% fetal bovine serum, 648 Wg/ml L-alanyl-L-gluta-
mine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin [31]. For ex-
periments, cell populations were used between cumulative population
doubling levels 12^25.
2.3. Cell treatment
Fibroblasts were treated with BC as previously described [21]. In
brief, BC (type II; Sigma, Deisenhofen, Germany) was prepared as a
water-soluble methyl-L-cyclodextrin formulation. Con£uent ¢broblast
monolayers were given phenol red-free medium which was supple-
mented with 0.5 or 5 WM BC, or vehicle alone. All cells obtained
the same amounts of vehicle with a non-toxic ¢nal concentration of
methyl-L-cyclodextrin below 0.2% [32]. Treatment with BC was car-
ried out for 7 days until UV irradiation.
NaN3 (Fluka, Buchs, Switzerland) was prepared as a 1 M stock
solution in Hanks’ balanced salt solution (HBSS) (Gibco BRL, Pais-
ley, Scotland). Prior to UV irradiation, cells were washed twice and
then covered with 0^100 mM NaN3 [20,33] in HBSS. Treatment with
NaN3 was carried out for 15 min and continued during the UV
irradiation period [34].
2.4. UV irradiation
Cells were irradiated with UV light as described [21]. In brief, irra-
diation was carried out in a UV irradiation chamber (Dr. Groebel UV
Elektronik, Ettlingen, Germany) at 37‡C. For irradiation with UVA
light (20 J/cm2), a UVA light source (TLD15W/05 lamps, Philips,
Hamburg, Germany) was used which emitted radiation in the range
of 300^460 nm with a maximum at 365 nm and an irradiance of 3.3
mW/cm2. For irradiation with UVB light (50 mJ/cm2), the light source
(F15T8UVB lamps, Philips) emitted radiation at wavelengths between
280 and 315 nm with an irradiance of 0.4 mW/cm2 [31]. The UV
chamber was equipped with a UV-MAT dosimeter and cosine-cor-
rected sensors RM-11UVA and RM-11UVB. The time periods of
UVA and UVB irradiation were 101 min and 2 min, respectively.
2.5. Western blot analysis
Cells were lysed in 10 mM Tris, pH 7.5, 0.9% (w/v) NP-40, 0.1% (w/
v) SDS, 1 mM Pefabloc (Biomol, Hamburg, Germany), 1 WM Leu-
peptin, 1 WM Pepstatin A (Calbiochem, CA, USA), and 50 U/ml
Benzonase (Merck, Darmstadt, Germany). Equal amounts of total
protein (20 Wg) were electrophoresed on a 12% SDS^polyacrylamide
gel (Laemmli system) under reducing conditions and electroblotted.
Immunodetections of IL-6 or HO-1 were carried out using a biotinyl-
ated goat polyclonal anti-hIL-6 IgG antibody (RpD Systems, Wies-
baden-Nordenstadt, Germany) or a rabbit polyclonal anti-HO-1 IgG
antibody (Stressgen, Victoria, BC, Canada). As secondary antibodies,
horseradish peroxidase (HRP)-conjugated anti-biotin IgG (New Eng-
land Biolabs, Schwalbach/Taunus, Germany) or HRP-conjugated
goat anti-rabbit IgG (New England Biolabs) were used. Immunoreac-
tions were visualized by means of a chemiluminescent detection sys-
tem with LumiGlo/Peroxide as the substrates (New England Biolabs).
2.6. Preparation of cDNA probe
A 559 bp cDNA probe for IL-6 was prepared with polyA mRNA
from HFP-1 dermal ¢broblasts. cDNA was synthesized by means of a
SuperScript kit (Gibco BRL). Based on the complete coding sequen-
ces of the human mRNA for IL-6 (accession no. M54894), oligonu-
cleotide primers for IL-6 (forward, 5P-CCA GTA CCC CCA GGA
GAA GA-3P ; reverse, 5P-CAT GCT ACA TTT GCC GAA GAG-3P)
were designed and purchased from Interactiva (Ulm, Germany). PCR
ampli¢cation was carried out in a PTC-200 DNA engine (MJ Re-
search Inc., Watertown, MA, USA) with a 50 Wl reaction mixture
containing 2 Wl cDNA, 3 U Taq DNA polymerase (Fermentas, Vil-
nius, Lithuania), 1 mM of each relevant deoxynucleoside triphosphate
(Amersham, Freiburg, Germany) and 50 pmol of each primer. Am-
pli¢cation was performed after incubation for 15 min at 72‡C running
45 cycles (1 min at 94.5‡C, 2 min at 60‡C, 3 min at 72‡C), followed by
10 min at 72‡C. The ampli¢ed DNA fragment of IL-6 was cloned into
the pCRII-TOPO vector (Invitrogen, Groningen, The Netherlands).
Sequencing of plasmids was performed by 4base lab GmbH (Reutlin-
gen, Germany) and the nucleotide sequence of the cloned PCR prod-
uct was found to be 100% identical to human IL-6 mRNA. The
speci¢c DNA fragment of IL-6 was isolated from 40 Wg vector using
EcoRI (Fermentas).
For detection of L-actin, a 680 bp cDNA probe which had been
cloned into the pZeroTM-1 vector (Invitrogen) was obtained as a kind
gift from PD Dr. Ju«rgen Frank, Department of Biological Chemistry
and Nutrition, University of Hohenheim (Stuttgart, Germany). The
two probes for IL-6 and L-actin were labeled with digoxigenin (DIG)
using a DIG-High Prime kit (Boehringer Mannheim, Mannheim, Ger-
many).
Fig. 1. BC stimulates UVA induction of IL-6 protein expression in
HFP-1. Cells were treated with BC or vehicle alone as indicated
and then irradiated with 20 J/cm2 UVA light, or they were sham-ir-
radiated (control). Cells were harvested at di¡erent time intervals
p.i. and analyzed for protein levels of IL-6. Western blots shown
are representatives of three independent experiments.
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2.7. Northern blot analysis
Total RNA was isolated by means of RNAWIZ1 reagent (Am-
bion, Austin, TX, USA). Northern blot hybridization was carried out
as previously described [21] using 12 Wg of total RNA. Hybridization
of nylon membranes was performed with DIG-labeled cDNA. For
chemiluminescent detection, a DIG-Luminescent Detection kit for
Nucleic Acids (Boehringer Mannheim) was used with CSPD as the
substrate.
3. Results and discussion
3.1. BC promotes UVA induction of IL-6
In irradiated cells, pre-incubation with 5 WM BC resulted in
a strong and time-dependent up-regulation of IL-6 protein
expression (Fig. 1). A signi¢cant increase in IL-6 expression
was ¢rst measured 6 h post irradiation (p.i.) and peaked at 12
h p.i. In vehicle-treated control cells as well as in cells treated
with a low dose of 0.5 WM BC, IL-6 protein expression was
not signi¢cantly induced following UVA irradiation. In non-
irradiated cells, a low constitutive protein expression of IL-6
could be detected which was not altered by BC treatment.
Similar e¡ects of BC on UVA induction of IL-6 were found
on the mRNA level (Fig. 2). Basal mRNA expression of IL-6
was not in£uenced by BC treatment in non-irradiated cells. In
UVA-irradiated cells, IL-6 mRNA expression was not in-
duced either in vehicle-treated control cells or in cells treated
with 0.5 WM BC. However, treatment with 5 WM BC resulted
in an induction of IL-6 mRNA expression at 2 h p.i.
These results demonstrate that BC modulates the expres-
sion of pro-in£ammatory IL-6 in UVA-irradiated cells. Based
on literature data, an increase of IL-6 expression in vehicle-
treated control cells following UVA exposure on both protein
and mRNA levels was expected in this study [23,24,26,35].
Di¡erences to previous reports can be explained by other
conditions of UVA exposure and time points investigated.
In our system, UVA alone was not su⁄cient to obtain a mea-
surable response. We observed induction of IL-6 by 20 J/cm2
UVA light when cells were irradiated in the presence of deu-
terium oxide, which enhances the lifetime of the UVA e¡ector
species 1O2 (data not shown). In conclusion, these data sug-
gest that treatment with BC leads to an increased formation
of reactive oxygen species in UVA-irradiated cells and it
might be hypothesized that increased amounts of 1O2 are
generated.
3.2. NaN3 attenuates the e¡ect of BC on UVA induction of
stress genes
In order to investigate the role of 1O2 in the increase of
IL-6 induction by BC, we used a for skin ¢broblasts well-
established system of NaN3 treatment [26,36^38]. NaN3 was
used at non-toxic doses of 0^100 mM [34]. Induction of IL-6
was determined 12 h p.i. on the protein level (Fig. 3) and
compared to UVA induction of HO-1. In sham-irradiated
cells, NaN3 had no in£uence on basal protein levels of both
IL-6 and HO-1, neither in vehicle-treated control cells nor in
BC-treated cells. In UVA-irradiated cells, NaN3 substantially
Fig. 2. BC stimulates UVA induction of IL-6 mRNA expression.
HFP-1 skin ¢broblasts were treated as described in Fig. 1. Total
RNA was isolated at 2 h p.i. and mRNA levels were analyzed by
Northern blotting using DIG-labeled cDNA probes for IL-6 and
L-actin. Blots are representatives of two independent experiments.
Fig. 3. NaN3 reduces enhanced UVA induction of IL-6 and HO-1 protein expression. HFP-1 skin ¢broblasts were treated with BC and/or
NaN3, or vehicles alone as indicated. Then cells were irradiated with 20 J/cm2 UVA light, or were sham-irradiated (control). Cells were har-
vested at 12 h p.i. and analyzed for protein levels of IL-6 and HO-1. Western blots shown are representatives of three independent experi-
ments.
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decreased levels of IL-6 in vehicle-treated and BC-treated
cells. Furthermore, our data show that UVA induction of
stress genes which is stimulated by BC is not solely due to
the action of 1O2 but, at least in part, to other oxidants as
NaN3 was not able to entirely suppress IL-6 and HO-1 up-
regulation in irradiated cells. And what is more, BC seems not
to act as a 1O2 quencher.
It is known that NaN3 with equal e⁄ciency scavenges not
only 1O2 but also hydroxyl radicals. However, Basu-Modak
and Tyrrell [20] presented evidence that 1O2 is the main e¡ec-
tor of HO-1 induction, and that the hydroxyl radical, which is
also generated by UVA light [39], has no signi¢cant e¡ect on
UVA-induced HO-1 induction [20]. Consequently, it seemed
reasonable to use NaN3 as speci¢c 1O2 quencher for the
present study. A role of hydroxyl radicals in the UVA induc-
tion of IL-6 is not known and cannot be excluded. Prelimi-
nary studies using deuterium oxide to increase the lifetime of
1O2 resulted in increased protein levels of IL-6 and HO-1
following UVA irradiation in vehicle-treated control cells
and cells treated with 0.5 WM BC. In cells treated with 5 WM
BC plus UVA light, the use of deuterium oxide caused cell
death (data not shown). Further studies are necessary to
clearly de¢ne the species involved in the UVA-induced stress
response in BC-treated cells.
3.3. BC has no e¡ect on IL-6 and HO-1 protein expressions in
UVB-irradiated cells
Irradiation with UVB light did not result in a signi¢cant
increase in protein levels of IL-6 and HO-1 (Fig. 4) neither
with nor without pre-treatment with BC. Up-regulation of
IL-6 and HO-1 in human skin ¢broblasts by UVB light has
been previously described by other authors. In literature,
UVB light has been reported to be an important inducer of
IL-6, but it has only weak e¡ects on HO-1 [19,25].
UVA light is the main source of photo-oxidative stress in
skin, however, UVB light also has an oxidative component
[40]. Our data indicate that in UVB-irradiated cells, the pres-
ence of BC does not enhance generation of reactive oxygen
species which could have resulted in an up-regulation of IL-6
or HO-1. Obviously, the described e¡ects of BC on the in-
duction of HO-1 and in£ammatory IL-6 occur speci¢cally
when cells are irradiated with UVA light.
It should be noted that irradiation with UV light was car-
ried out using light sources with irradiances comparable to the
sunlight in a southern hemisphere summer [41]. Furthermore,
absolute doses of UVA and UVB light were chosen which
may not cause signi¢cant erythema in humans of the cauca-
sian skin type [42], and which are considered non-toxic for
cultured human skin ¢broblasts [43]. The UVB dose was 400-
fold smaller than the UVA dose, however, the same or similar
doses are usually used to study UV-induced expression of
IL-6 and HO-1 in skin cells [19,25,26,35,43]. This is due to
the fact that humans are exposed to much less UVB radiation
when compared to UVA as summer daylight comprises of
approximately 5% UVB and 95% UVA light. Nonetheless,
many biological e¡ects of UV exposure are much greater at
shorter wavelengths, and UVA light is estimated to contribute
only around 20% to the detrimental e¡ects of sun exposure
[44].
At present, the role of BC in UV-light exposed skin cannot
be de¢ned clearly. As recently reviewed, human and experi-
mental studies investigating various biological endpoints and
using di¡erent model systems have resulted in a number of
contradictory data [4]. However, it may be expected that BC
exerts anti-oxidative and anti-in£ammatory properties in hu-
man skin via quenching photochemically generated 1O2, and
thus provides photoprotection.
From the presented study we conclude that BC does not
seem to act as an anti-oxidant and 1O2 quencher under UVA
exposure in vitro. In contrast, BC stimulates under cell culture
conditions a stress response in UVA-irradiated skin ¢bro-
blasts, which involves HO-1 and the in£ammatory cytokine
IL-6. Further studies are necessary to clarify whether such an
e¡ect of BC also exists in animals and humans where BC acts
as part of a complex anti-oxidant network [45]. If veri¢ed in
vivo, a pro-in£ammatory and pro-oxidative potential of BC
might promote UV damage in skin.
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